Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors
- 13 September 2018
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 118 (6) , 983-990
Abstract
Background and Objectives: Various treatment options exist for patients with metastatic pancreatic neuroendocrine tumors (PNETs). Surgical resection with pancreaticoduodenectomy (PD) typically reserved for patients with limited disease. Definitive data are lacking to support either the resection of primary PNET in the metastatic setting or for surgical debulking of metastatic lesions.Methods: We conducted an analysis of the National Cancer Database (NCDB) using the pancreatic cancer Participant User File. Thirty‐ and 90‐day mortality rates and survival rates were determined for patients undergoing PD for primary tumor resection and compared with patients who had no surgery or metastasectomy. The Kaplan‐Meier method was used to compare survival time. Cox regression models were used to assess factors independently associated with overall survival time.Results: Resection of the primary tumor or metastatic disease each significantly improved overall survival time compared with no resection. Adding metastasectomy to PD resulted in an incremental increase in overall survival time. Both PD and metastasectomy are independently associated with overall survival time.Conclusions: Our report highlights the potential for survival time benefit in appropriately selected patients who undergo PD in the setting of metastatic PNET.Keywords
This publication has 18 references indexed in Scilit:
- Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre studyHPB, 2013
- Metastatic Nonfunctioning Pancreatic Neuroendocrine Carcinoma to Liver: Surgical Treatment and OutcomesJournal of the American College of Surgeons, 2012
- Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for ResectionArchives of Surgery, 2011
- Effect of Hospital Volume, Surgeon Experience, and Surgeon Volume on Patient Outcomes After PancreaticoduodenectomyArchives of Surgery, 2010
- Surgical Management of Hepatic Neuroendocrine Tumor Metastasis: Results from an International Multi-Institutional AnalysisAnnals of Surgical Oncology, 2010
- Pancreatic neuroendocrine tumorsCancer, 2009
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Population-Based Study of Islet Cell CarcinomaAnnals of Surgical Oncology, 2007
- Defining Morbidity after Pancreaticoduodenectomy: Use of a Prospective Complication Grading SystemJournal of the American College of Surgeons, 2007
- The National Cancer Data Base: A clinical surveillance and quality improvement toolJournal of Surgical Oncology, 2003